IR Biosciences Holdings Inc.
IR Biosciences Holdings Inc.
Your view on IRBS
Overview
What the company does, where it operates, and who runs it.
About IR Biosciences Holdings Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Chet Leach D.A.B.T.
- Headquarters
- 8777 East Via de Ventura, Scottsdale, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Chet Leach D.A.B.T.
- Headquarters
- 8777 East Via de Ventura, Scottsdale, US
IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States. The company, through its subsidiary, ImmuneRegen BioSciences, Inc., engages in the research and development of therapies in the areas of pulmonary fibrosis, influenza infection, and radiation-induced Neutropenia. It is involved in the development of Homspera, and its derivates Radilex and Viprovex, for human stem cell stimulation, immune system stimulation and anti-infective activity, vaccine adjuvancy, and wound healing. IR BioSciences Holdings, Inc. was founded in 1999 and is headquartered in Scottsdale, Arizona.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.